Llwytho...
Vedolizumab: toward a personalized therapy paradigm for people with ulcerative colitis
Ulcerative colitis (UC) is a chronic relapsing and remitting inflammatory bowel disease, with a characteristic leukocytic infiltration of the mucosa. Immunosuppression including anti-TNF-α therapy is a mainstay of treatment for many; however, systemic immunosuppression is not universally effective a...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Clin Exp Gastroenterol |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Dove Medical Press
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5344414/ https://ncbi.nlm.nih.gov/pubmed/28424557 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEG.S110547 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|